NEW YORK ( TheStreet) -- AVEO Pharmaceuticals (Nasdaq: AVEO) hit a new 52-week low Wednesday as it is currently trading at $11.22, below its previous 52-week low of $11.28 with 36,912 shares traded as of 10:10 a.m. ET. Average volume has been 272,200 shares over the past 30 days. AVEO has a market cap of $534.4 million and is part of the health care sector and drugs industry. Shares are down 28.7% year to date as of the close of trading on Tuesday. AVEO Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of cancer therapeutics. The company has a P/E ratio of 16.8, above the average drugs industry P/E ratio of 16.6 and below the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter